Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,200
Closed -$209K 181
2021
Q4
$209K Sell
1,200
-800
-40% -$133K ﹤0.01% 179
2021
Q3
$331K Hold
2,000
﹤0.01% 200
2021
Q2
$360K Hold
2,000
﹤0.01% 184
2021
Q1
$386K Hold
2,000
﹤0.01% 166
2020
Q4
$404K Hold
2,000
﹤0.01% 215
2020
Q3
$420K Hold
2,000
0.01% 200
2020
Q2
$439K Sell
2,000
-800
-29% -$160K 0.01% 176
2020
Q1
$485K Hold
2,800
0.01% 159
2019
Q4
$430K Hold
2,800
0.01% 200
2019
Q3
$425K Buy
+2,800
New +$443K 0.01% 188

Other funds holding CLX

Bellevue Group's CLX Position: Q1 2022 in Review

Bellevue Group sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,200 shares — an estimated $209K sold.

Bellevue Group first reported a position in CLX in Q3 2019 and held it in 10 quarters. The position peaked at $485K in Q1 2020. 1,093 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Bellevue Group reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Bellevue Group sold 1,200 Clorox shares in Q1 2022, an estimated $209K.
  • Bellevue Group first reported a position in Clorox in Q3 2019 and held it in 10 quarters.
  • Bellevue Group's Clorox position peaked at $485K in Q1 2020.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.